Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2023-2029

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2023-2029

Product Code:464230

Published Date: Jan 06,2023

Pages: 124

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

LPI (LP Information)' newest research report, the “Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Forecast” looks at past sales and reviews total world Isothermal Nucleic Acid Amplification Technology (INAAT) sales in 2022, providing a comprehensive analysis by region and market sector of projected Isothermal Nucleic Acid Amplification Technology (INAAT) sales for 2023 through 2029. With Isothermal Nucleic Acid Amplification Technology (INAAT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isothermal Nucleic Acid Amplification Technology (INAAT) industry.

This Insight Report provides a comprehensive analysis of the global Isothermal Nucleic Acid Amplification Technology (INAAT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Isothermal Nucleic Acid Amplification Technology (INAAT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Isothermal Nucleic Acid Amplification Technology (INAAT) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isothermal Nucleic Acid Amplification Technology (INAAT) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isothermal Nucleic Acid Amplification Technology (INAAT).

The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Isothermal Nucleic Acid Amplification Technology (INAAT) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Isothermal Nucleic Acid Amplification Technology (INAAT) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Isothermal Nucleic Acid Amplification Technology (INAAT) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Isothermal Nucleic Acid Amplification Technology (INAAT) players cover Grifols, Hologic, Abbott Laboratories, BD, Meridian Bioscience, Eiken Chemical, Quidel Corporation, QIAGEN and bioMerieux, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Isothermal Nucleic Acid Amplification Technology (INAAT) market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    by Technology
        Loop-mediated Isothermal Amplification
        Nucleic Acid Sequence-based Amplification
        Rolling Circle Amplification
        Single Primer Isothermal Amplification
        Helicase-dependent Isothermal DNA Amplification
        Recombinase Polymerase Amplification
        Strand Displacement Amplification
    by Product Type
        Assay
        Kits
        Reagents

Segmentation by application
    Infectious Disease Diagnosis
    Blood Screening
    Cancer Diagnosis
    Cancer Research and Laboratory Research
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Grifols
    Hologic
    Abbott Laboratories
    BD
    Meridian Bioscience
    Eiken Chemical
    Quidel Corporation
    QIAGEN
    bioMerieux
    Tecan
    DiaSorin
    Thermo Fisher Scientific
    Illumina
    New England Biolabs
    TwistDx
    Mast Group
    Lucigen Corporation
    Ustar Biotechnologies
    Genomtec
    Jena Bioscience
    OptiGene
    Sysmex Corporation
    Premier Biosoft
    mFluiDx
    Cangene